May 6, 2019 8:30 am EDT Eyenovia Announces Presentation of Successful Phase 3 Studies at the ASCRS-ASOA Annual Meeting
May 1, 2019 8:30 am EDT Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results
Mar 13, 2019 8:30 am EDT Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results
Feb 25, 2019 8:30 am EST Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis
Feb 13, 2019 8:30 am EST Eyenovia confirms expanded MicroProst Phase III indication to enroll broad patient population for IOP lowering
Feb 6, 2019 8:30 am EST Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
Jan 30, 2019 7:00 am EST Eyenovia Announces Positive Results in the MicroStat MIST-1 Phase III Registration Study for Mydriasis